Vitamin D and Neurological Diseases: An Endocrine View
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Vitamin D system comprises hormone precursors, active metabolites, carriers, enzymes, and receptors involved in genomic and non-genomic effects. In addition to classical bone-related effects, this system has also been shown to activate multiple molecular mediators and elicit many physiological functions. In vitro and in vivo studies have, in fact, increasingly focused on the “non-calcemic” actions of vitamin D, which are associated with the maintenance of glucose homeostasis, cardiovascular morbidity, autoimmunity, inflammation, and cancer. In parallel, growing evidence has recognized that a multimodal association links vitamin D system to brain development, functions and diseases. With vitamin D deficiency reaching epidemic proportions worldwide, there is now concern that optimal levels of vitamin D in the bloodstream are also necessary to preserve the neurological development and protect the adult brain. The aim of this review is to highlight the relationship between vitamin D and neurological diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Holick, M. F. (2007) · New England Journal of Medicine · doi:10.1056/nejmra070553 · Cited by 13,720
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Querfurth, H. W., & LaFerla, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0909142 · Cited by 4,569
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
The International Multiple Sclerosis Genetics Consortium & The Wellcome Trust Case Control Consortium 2 (2011) · Nature · doi:10.1038/nature10251 · Cited by 2,697
Vitamin D deficiency: a worldwide problem with health consequences
Holick, M. F., & Chen, T. C. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.4.1080s · Cited by 2,689 · cited 1×
“There is now consistent evidence showing that several “non-calcemic” effects of vitamin D metabolites occur in vitro and in vivo, and increasing consideration is given to vitamin D status as a marker of general health, since low vitamin D levels are associated with the development and progress of autoimmunity, infecti…”
BackgroundKiernan, M. C., Vucic, S., Cheah, B. C., Turner, M. R., Eisen, A., Hardiman, O., Burrell, J. R., & Zoing, M. C. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61156-7 · Cited by 2,603
Alterations of the human gut microbiome in multiple sclerosis
Jangi, S., Gandhi, R., Cox, L. M., Li, N., von Glehn, F., Yan, R., Patel, B., Mazzola, M. A., Liu, S., Glanz, B. L., et al. (2016) · Nature Communications · doi:10.1038/ncomms12015 · Cited by 1,307 · cited 1×
“Emerging cross-sectional, case-control studies have shown that microbiota composition differs between MS subjects and controls [58,59].”
BackgroundMolecular biology of amyotrophic lateral sclerosis: insights from genetics
Pasinelli, P., & Brown, R. H. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1971 · Cited by 1,107
The Free Hormone Hypothesis: A Physiologically Based Mathematical Model*
MENDEL, C. M. (1989) · Endocrine Reviews · doi:10.1210/edrv-10-3-232 · Cited by 961
Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls
Chen, J., Chia, N., Kalari, K. R., Yao, J. Z., Novotna, M., Paz Soldan, M. M., Luckey, D. H., Marietta, E. V., Jeraldo, P. R., Chen, X., et al. (2016) · Scientific Reports · doi:10.1038/srep28484 · Cited by 933 · cited 1×
“Emerging cross-sectional, case-control studies have shown that microbiota composition differs between MS subjects and controls [58,59].”
BackgroundNew clues about vitamin D functions in the nervous system
Garcion, E., Wion-Barbot, N., Montero-Menei, C. N., Berger, F., & Wion, D. (2002) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(01)00547-1 · Cited by 904
Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis
Simpson, S., Blizzard, L., Otahal, P., Van der Mei, I., & Taylor, B. (2011) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2011.240432 · Cited by 718 · cited 1×
“A direct relationship has been observed between latitude and the prevalence of MS, which suggests a role for UV radiation and vitamin D in MS development [65].”
BackgroundThe gut microbiome in human neurological disease: A review
Tremlett, H., Bauer, K. C., Appel‐Cresswell, S., Finlay, B. B., & Waubant, E. (2017) · Annals of Neurology · doi:10.1002/ana.24901 · Cited by 535
Bischoff-Ferrari, H. A., Dawson-Hughes, B., Orav, E. J., Staehelin, H. B., Meyer, O. W., Theiler, R., Dick, W., Willett, W. C., & Egli, A. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.7148 · Cited by 511
Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI
Jack, C. R., Shiung, M. M., Weigand, S. D., O’Brien, P. C., Gunter, J. L., Boeve, B. F., Knopman, D. S., Smith, G. E., Ivnik, R. J., Tangalos, E. G., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000180958.22678.91 · Cited by 492
Brown, J., Bianco, J. I., McGrath, J. J., & Eyles, D. W. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00303-3 · Cited by 377
Nutritional supplementation for hip fracture aftercare in older people
Avenell, A., Smith, T. O., Curtain, J. P., Mak, J. C., & Myint, P. K. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001880.pub6 · Cited by 373
American Geriatrics Society Workgroup on Vitamin D Supplementation for Older Adults (2014) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12631 · Cited by 313
25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services
Buell, J. S., Dawson-Hughes, B., Scott, T. M., Weiner, D. E., Dallal, G. E., Qui, W. Q., Bergethon, P., Rosenberg, I. H., Folstein, M. F., Patz, S., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181beecb7 · Cited by 288
Vitamin D as a neurosteroid affecting the developing and adult brain
Groves, N. J., McGrath, J. J., & Burne, T. H. J. (2014) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071813-105557 · Cited by 256 · cited 5×
“Interestingly, animal and human data have suggested that vitamin D status, particularly vitamin D deficiency, may intervene during adulthood to modulate the exacerbation of inherent brain disorders and/or impair the recovery from brain stressors [29].”
BackgroundInfluential25-Hydroxyvitamin D levels and cognitive performance and decline in elderly men
Slinin, Y., Paudel, M. L., Taylor, B. C., Fink, H. A., Ishani, A., Canales, M. T., Yaffe, K., Barrett-Connor, E., Orwoll, E. S., Shikany, J. M., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181c7197b · Cited by 193 · cited 2×
“followed up the association between lower 25(OH)D levels and cognitive decline in aged individuals (>65 years) for four years [192,198].”
BackgroundResultVitamin D Is Associated With Cognitive Function in Elders Receiving Home Health Services
Buell, J. S., Scott, T. M., Dawson-Hughes, B., Dallal, G. E., Rosenberg, I. H., Folstein, M. F., & Tucker, K. L. (2009) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glp032 · Cited by 186
Cui, X., Pelekanos, M., Liu, P.-Y., Burne, T. H. J., McGrath, J. J., & Eyles, D. W. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.01.035 · Cited by 182
The role of insulin-like growth factor I components in the regulation of vitamin D
Manuel Gomez, J. (2006) · Current Pharmaceutical Biotechnology · doi:10.2174/138920106776597621 · Cited by 96 · cited 1×
“In addition, vitamin D increases neurotrophic factors [242], and acts to promote the effectiveness of IGF-I by increasing expression of IGF-I receptors [243], which promotes survival and motor function parameters in SOD1 animals [244].”
BackgroundCamu, W., Tremblier, B., Plassot, C., Alphandery, S., Salsac, C., Pageot, N., Juntas-Morales, R., Scamps, F., Daures, J.-P., & Raoul, C. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.11.005 · Cited by 95
Cerebrospinal fluid proteome comparison between multiple sclerosis patients and controls
Kroksveen, A. C., Guldbrandsen, A., Vedeler, C., Myhr, K. M., Opsahl, J. A., & Berven, F. S. (2012) · Acta Neurologica Scandinavica · doi:10.1111/ane.12029 · Cited by 80
Vitamin D deficiency and its supplementation in patients with amyotrophic lateral sclerosis
Karam, C., Barrett, M. J., Imperato, T., MacGowan, D. J. L., & Scelsa, S. (2013) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2013.01.011 · Cited by 74
Bhargava, P., Cassard, S., Steele, S. U., Azevedo, C., Pelletier, D., Sugar, E. A., Waubant, E., & Mowry, E. M. (2014) · Contemporary Clinical Trials · doi:10.1016/j.cct.2014.10.004 · Cited by 69
Cited by
The serum vitamin D metabolome: what we know and what is still to discover
Tuckey, R. C., Cheng, C. Y. S., & Slominski, A. T. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2018.09.003 · Cited by 245
Crosstalk between bone and brain in Alzheimer's disease: Mechanisms, applications, and perspectives
Liu, Z., Liu, M., Xiong, Y., Wang, Y., & Bu, X. (2024) · Alzheimer's & Dementia · doi:10.1002/alz.13864 · Cited by 39
Calcium and Vitamin D Supplementation. Myths and Realities with Regard to Cardiovascular Risk
Muscogiuri, G., Barrea, L., Altieri, B., Di Somma, C., Bhattoa, H. P., Laudisio, D., Duval, G. T., Pugliese, G., Annweiler, C., Orio, F., et al. (2019) · Current Vascular Pharmacology · doi:10.2174/1570161117666190408165805 · Cited by 27
Self-citation
Metadata
- Authors
- Di Somma, C., Scarano, E., Barrea, L., Zhukouskaya, V. V., Savastano, S., Mele, C., Scacchi, M., Aimaretti, G., Colao, A., & Marzullo, P.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2017-11-21
- Volume
- 18
- Issue
- 11
- Pages
- 2482
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2770085448
- Cited by
- 223
- References
- 29
- FWCI
- 19.84
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.